|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM346995515 |
| 003 |
DE-627 |
| 005 |
20231226032758.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2022.109140
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1156.xml
|
| 035 |
|
|
|a (DE-627)NLM346995515
|
| 035 |
|
|
|a (NLM)36184051
|
| 035 |
|
|
|a (PII)S1521-6616(22)00221-2
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Ghods, Atri
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a TNF-α is produced by, but not limited to, T helper 1, 2, and 17 in breast tumor-draining lymph nodes
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 25.11.2022
|
| 500 |
|
|
|a Date Revised 26.12.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Letter
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Tumor Necrosis Factor-alpha
|2 NLM
|
| 700 |
1 |
|
|a Mehdipour, Fereshteh
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Rasolmali, Reza
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Talei, Abdol-Rasoul
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ghaderi, Abbas
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 245(2022) vom: 15. Dez., Seite 109140
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:245
|g year:2022
|g day:15
|g month:12
|g pages:109140
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2022.109140
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 245
|j 2022
|b 15
|c 12
|h 109140
|